- Cardiac arrest centers - czech national network project2016 | Faculty of Medicine in Pilsen
- Development of the Czech constitutionality in years 1618-1918, Proceedings of contributions from the international conference 6 - 9 October 2006, arr. by Karel Malý and Ladislav Soukup, Charles University,Karolinum, in: Legal History Studies No 40.2009 | Faculty of Mathematics and Physics, Faculty of Law
- Treatment and outcome of patients after cardiopulmonary resuscitation admitted to the intensive cardiac care unit2009 | Central Library of Charles University
- Risk Stratification to Predict Renal Survival in Anti-Glomerular Basement Membrane Disease2023 | First Faculty of Medicine
- PSPU concert with premieres of works by contemporary composers (Modlitebna ČCE, Korunní 60)Publication without faculty affiliation
- PSPU concert with premieres of works by contemporary composers (Na Marjánce Hall, Prague 6)Publication without faculty affiliation
- Determinants of therapeutic lag in multiple sclerosis2021 | First Faculty of Medicine
- Aflibercept Plus FOLFIRI vs. Placebo Plus FOLFIRI in Second-Line Metastatic Colorectal Cancer: a Post Hoc Analysis of Survival from the Phase III VELOUR Study Subsequent to Exclusion of Patients who had Recurrence During or Within 6 Months of Completing Adjuvant Oxaliplatin-Based Therapy2016 | Publication without faculty affiliation
- Stereospecificity in vanadium Schiff base complexes: Formation, crystallization and epimerization processes2015 | Faculty of Science
- Concert in the Church of the Three Kings, LibouchecPublication without faculty affiliation
- Is breastfeeding in MS harmful or not? An answer from real-world Czech data2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine
- COVID-19 vaccination and relapse activity: A nationwide cohort study of patients with multiple sclerosis in Denmark2024 | First Faculty of Medicine
- Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study2012 | First Faculty of Medicine
- Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the CONFIRM study2013 | First Faculty of Medicine
- Treatment Response Score to Glatiramer Acetate or Interferon Beta-1a2021 | First Faculty of Medicine
- Natalizumab, Fingolimod, and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis2021 | First Faculty of Medicine
- Comparing switch to ocrelizumab, cladribine or natalizumab after fingolimod treatment cessation in multiple sclerosis2022 | First Faculty of Medicine
- The effect of oral sodium loading and saline infusion on direct active renin in healthy volunteers2011 | Faculty of Medicine in Hradec Králové
- Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis2022 | First Faculty of Medicine
- Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study2012 | Second Faculty of Medicine
- Consistent efficacy of daclizumab beta across patient demographic and disease activity subgroups in patients with relapsing-remitting multiple sclerosis2017 | First Faculty of Medicine
- A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis2014 | First Faculty of Medicine
- Comparative Effectiveness and Cost-Effectiveness of Natalizumab and Fingolimod in Patients with Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis in the United Kingdom2022 | First Faculty of Medicine
- Primary aldosteronism in a general population sample. The Czech post-MONICA study2020 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI2023 | First Faculty of Medicine
- Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod2018 | First Faculty of Medicine
- Relationship between Patient Preferences, Attitudes to Treatment, Adherence, and Quality of Life in New Users of Teriflunomide2022 | First Faculty of Medicine
- Comparison Between Dimethyl Fumarate, Fingolimod, and Ocrelizumab After Natalizumab Cessation2023 | First Faculty of Medicine
- Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis2023 | First Faculty of Medicine, Third Faculty of Medicine
- Sleep health composites are associated with the risk of heart disease across sex and race2022 | Second Faculty of Medicine